The company installed a ZSE-3D twin screw extrusion system at its Somerville, NJ process laboratory.
On Aug. 27, 2018, Leistritz announced the installation of a ZSE-3D twin-screw extrusion system at its Somerville, NJ process laboratory. The system facilitates the development and production of 3D filaments from a co-rotating or counter-rotating twin screw extruder.
According to the company, direct extrusion of raw materials enables rapid product sampling and also results in one-less heat and shear history as compared to two-step processes, which is beneficial for heat and shear sensitive formulations.
The system features the following:
The company states that the system is suitable for in-line compounding of excipients with APIs, to quickly develop new filaments and formulations. Formulations can be modified extemporaneously for rapid sampling of filaments with different formulation percentages. A sample can be produced every 10 minutes. The filament system is configured for water-soluble and high-temperature applications.
Source: Leistritz
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.